rSLPI and EPI-hNE4 are two neutrophil elastase inhibitors, which have shown beneficial effects in CF, but large cohort trials are still lacking (McElvaney et al., 1993; Grimbert et al., 2003). Here, ELANE is linked to cystic fibrosis.